Research highlights featuring work on Zika and Marburg vaccines, investigating how Ebola virus infects cells and finding where rebound HIV infection originates from.

Research highlights including the next phase of the Strong Heart Study, TB advancements, Zika vaccine, an award-winning children’s game and more.

SECRETS OF A CRITICAL SCHISTOSOMIASIS DRUG UNLOCKED For decades, no one really knew how the drug praziquantel treated schistosomiasis, a parasitic worm infection afflicting more than 200 million people worldwide. Texas Biomed Professor Tim Anderson, PhD, and his team, and researchers at the Medical College of Wisconsin, determined how the drug works on the molecular […]

TEXAS BIOMED AND PARTNERS DISCOVER NEW, POTENT COVID-19 ANTIBODY COCKTAIL Texas Biomed researchers, led by Professor Luis Martinez-Sobrido, PhD, and collaborators at the University of Alabama at Birmingham, discovered a COVID-19 antibody cocktail that appears effective against all variants and other coronaviruses. The cocktail includes two antibodies that target different parts of the virus’s spike protein […]

Under the leadership of President/CEO Dr. Larry Schlesinger and Executive Vice Presidents Dr. Joanne Turner and Bruce Edwards, Texas Biomed embarked on a journey in 2017 to establish a new strategic direction. The 10-year strategic plan was adopted in 2018, providing a road map to grow Texas Biomed’s people, places and programs. 2018 2019 2020 […]